Tradestie Institutional Equity Comparison Engine

SRZN vs PLUR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SRZN Overall Edge

SRZN Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Surrozen, Inc. Common (SRZN) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while PLUR counters with relative strength in Valuation. Fundamentally, SRZN trades at N/M Forward P/E with -485.4% operating margin (+408.6% YoY revenue) versus PLUR at 3.6x Forward P/E and -2454.5% operating margin (-15.8% YoY). In options structure, SRZN sits in CONSOLIDATION (5th %ile IV; Dealer Gamma Walls on Pro) against PLUR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner PLUR
SRZN N/M vs PLUR 3.6x Fwd P/E
Growth & Margin Winner SRZN
Op Margin -485.4% vs -2454.5% ยท YoY +408.6% vs -15.8%
Momentum & Technical Winner SRZN
1Y +130.6% vs -78.8% ยท 52W Pos 69% vs 2%
Options & Structure Winner SRZN
CONSOLIDATION (5th %ile IV) vs UNCLASSIFIED (N/A IV)
SRZN NASDAQ
Surrozen, Inc. Common
Biological Products, (No Disgnostic Substances)
$29.93
-7.38% 1D
Market Cap $602.5M
1M Return +25.57%
1Y Return +130.62%
Forward P/E N/M
Unified AI Score
33.2 / 100 SELL
Tech 50.0 Fund 34.0 Flow 65.0 Mom 40.0
PLUR US Equity
Pluri Inc.
Biological Products, (No Diagnostic Substances)
$0.94
-9.19% 1D
Market Cap $15.1M
1M Return +11.09%
1Y Return -78.78%
Forward P/E 3.6x
Unified AI Score
28.8 / 100 SELL
Tech 15.0 Fund 34.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SRZN +130.62% PLUR -78.78% Spread: +206.15 pp (SRZN Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period SRZN Revenue PLUR Revenue SRZN Op. Margin PLUR Op. Margin Margin Edge
FY2018 N/A $0M N/A -67462.0% PLUR
FY2019 N/A $0M N/A -65800.0% PLUR
FY2020 N/A $0M N/A -128156.5% PLUR
FY2022 $10M $0M -354.7% -17774.8% SRZN
FY2023 N/A $0M N/A -9493.4% PLUR
FY2024 $10M $0M -239.7% -6796.9% SRZN
FY2025 $0M $0M -1210.6% -1659.9% SRZN
FY2026 N/A $0M N/A -2454.5% PLUR

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SRZN (7) vs PLUR (2)
Institutional Metric SRZN PLUR Criterion Row Winner
Market Capitalization Scale $602.5M $15.1M Larger Scale SRZN
Trailing P/E Ratio Valuation N/M 3.6x Lower Multiple PLUR
Forward P/E Ratio Valuation N/M 3.6x Lower Multiple PLUR
Revenue Growth (YoY) Growth +408.6% -15.8% Higher Growth SRZN
Operating Margin (TTM) Profitability -485.4% -2454.5% Higher Margin SRZN
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -62.8% -1022.0% Higher ROE SRZN
52-Week Range Position Momentum 69% ($12โ€“$38) 2% ($1โ€“$5) Stronger Trend SRZN
Beta / 30D Volatility Risk Regime 1.28ฮฒ ยท 66% Vol 0.80ฮฒ ยท 102% Vol Lower Realized Risk SRZN
Unified Institutional Score Composite Signal 33.2 / 100 (SELL) 28.8 / 100 (SELL) Higher Composite SRZN

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SRZN vs PLUR Buy Guide
SRZN CONSOLIDATION
38d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live SRZN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PLUR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PLUR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SRZN nor PLUR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.